Pasar al contenido principal

NANOPARTICULAS MULTIFUNCIONALES PARA LA OBTENCION DE BIOIMAGENES MEDIANTE LUMINISCENCIA, RESONANCIA MAGNETICA Y TOMOGRAFIA COMPUTARIZADA DE RAYOS X

PRE2019-090170

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Europium doped-double sodium bismuth molybdate nanoparticles as contrast agents for luminescence bioimaging and X-ray computed tomography

  • Calderón-Olvera, Roxana M.
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Monje-Moreno, José Manuel
  • Muñoz-Ruiz, Manuel
  • Gómez-González, Elisabet
  • Arroyo, Encarnación
  • Torres Herrero, Beatriz
  • Fuente, Jesús M. de la
  • Ocaña, Manuel
A one-pot method for the synthesis of uniform Eu3+-doped NaBi(MoO4)2 nanoparticles with an ellipsoidal shape and tetragonal crystal structure functionalized with polyacrylic acid is reported for the first time in the literature. The method is based on a homogeneous precipitation reaction from solutions in an ethylene glycol/water medium containing appropriate bismuth, sodium, and molybdate precursors and polyacrylic acid. The luminescence properties (excitation and emission spectra and luminescence lifetime) of such nanoparticles are evaluated for different Eu3+ doping levels, finding an intense red emission for all synthesized samples. The X-ray attenuation properties of the nanoparticles have been also analyzed, which were found to be better than those of a commercially computed tomography contrast agent (iohexol). The dispersibility of the nanoparticles in a physiological medium was also analyzed, finding that they could be well dispersed in a 2-N-morpholinoethanesulfonic acid monohydrate medium (pH = 6.5). Finally, the cell viability of such a phosphor has been analyzed using MIA-PaCa-2 cells and its in vivo toxicity has been evaluated using the nematode Caenorhabditis elegans model finding no significant toxicity in both cases up to a nanoparticle concentration of 100 μg mL−1, which is within the range required for most in vivo applications. The developed Eu3+-doped NaBi(MoO4)2 nanoparticles are, therefore, excellent candidates for their use as bimodal probes for luminescence imaging and X-ray computed tomography., This publication is part of the I + D + I Grant RTI2018-094426-B-I00 and funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. R. M. Calderón-Olvera acknowledges the financial support from the CONACYT-801024 postdoctoral grant. E. Gómez-González acknowledges the financial support from the FPI program (PRE2019-090170). E. Arroyo acknowledges the grant FPU19/00527 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. B. T. is grateful for the FPU predoctoral contract (FPU19/01311) from Ministerio de Educación Cultura y Deporte (Spain). J. M. de la Fuente thanks DGA and Fondos Feder (Bionanosurf E15_17R) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB16/01/00263), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commission, European Regional Development Fund). This research was also funded by the European Commission NextGenerationEU (Regulation EU 2020/2094).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Carboxylate functionalized NaDy(MoO4)2 nanoparticles with tunable size and shape as high magnetic field MRI contrast agents

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Ocaña, Manuel
Uniform sodium-dysprosium double molybdate (NaDy(MoO4)2) nanoparticles having different morphologies (spheres and ellipsoids) and tunable size have been synthesized for the first time in literature. The procedure is based on a homogeneous precipitation process at moderated temperatures (≤220 °C) from solutions containing appropriated precursors dissolved in ethylene glycol-water mixtures, in the absence (spheres) or the presence (ellipsoids) of tartrate anions. The effects of the morphological characteristics (size and shape) of the nanoparticles on the magnetic relaxivity at high field (9.4 T) have been evaluated finding that the latter magnitude was higher for the spheres than for the ellipsoids, indicating their better suitability as contrast agents for high-field magnetic resonance imaging. Such nanoparticles have been successfully coated with polymers bearing carboxylate functional groups through a layer-by-layer process, which improves the colloidal stability of the nanoparticles in physiological media. It has been also found that the coating layer had no significant effects on the nanoparticles relaxivity and that such coated nanoparticles exhibited a high biocompatibility and a high chemical stability. In summary, we have developed NaDy(MoO4)2 based bioprobes which meet the required criteria for their use as contrast agents for high-field magnetic resonance imaging., This publication is part of the I + D + I Grants RTI2018-094426-B-I00 and CTQ2017-86655-R funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). E. Gómez-González acknowledges the financial support from the FPI program (PRE2019-090170)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based trimodal probes for near-infrared luminescent bioimaging, high-field magnetic resonance imaging, and X-ray computed tomography

  • Gómez-González, Elisabet
  • González-Mancebo, Daniel
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We have developed a trimodal bioimaging probe for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography using Dy3+ as the paramagnetic component and Nd3+ as the luminescent cation, both of them incorporated in a vanadate matrix. Among different essayed architectures (single phase and core–shell nanoparticles) the one showing the best luminescent properties is that consisting of uniform DyVO4 nanoparticles coated with a first uniform layer of LaVO4 and a second layer of Nd3+-doped LaVO4. The magnetic relaxivity (r2) at high field (9.4 T) of these nanoparticles was among the highest values ever reported for this kind of probes and their X-ray attenuation properties, due to the presence of lanthanide cations, were also better than those of a commercial contrast agent (iohexol) commonly used for X-ray computed tomography. In addition, they were chemically stable in a physiological medium in which they could be easily dispersed owing to their one-pot functionalization with polyacrylic acid, and, finally, they were non-toxic for human fibroblast cells. Such a probe is, therefore, an excellent multimodal contrast agent for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography., Financial support by Junta de Andalucía (P20_00182) is acknowledged. This publication is part of the I + D + I Grants RTI2018-094426-B-I00, PID2021-122328OB-I00, and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Multimodal lanthanide vanadate-based nanoparticles for T1 -T2 MRI and NIR luminescent imaging

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., F2 F2b_ FTIR spectrum of single-phase nanoparticles. F2c_ TGA curve of the single-phase nanoparticles. F2d_XRD pattern of the single-phase nanoparticles_ black. F2d_GdVO4 PDF_red. F2d_DyVO4 PDF_navy. F4 F4b_ XRD pattern of the core-shell nanoparticles_ black F4b_GdVO4 PDF_red. F4b_DyVO4 PDF_navy. F4c: FTIR spectrum of the core-shell nanoparticles. F4d: TGA curve of the core-shell nanoparticles. F6 F6_top_blue: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_top_red: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F6_bottom_blue: The transverse (1/T2) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_bottom_red: The transverse (1/T2) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F7 F7b_XRD pattern of the Dy@Y@Nd:Gd sample_black. F7b_DyVO4 PDF_grey. F7b_GdVO4 PDF_red F7b_YVO4 PDF_blue F7c_FTIR spectrum of the Dy@Y@Nd:Gd sample. F7d_TGA curve of the Dy@Y@Nd:Gd sample. F9 F9_blue: Relaxation rates (1/T1) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F9_red: Relaxation rates (1/T2) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F10 F10_top: Excitation spectrum for the Dy@Y@Nd:Gd sample. F10_ bottom: Emission spectrum for the Dy@Y@Nd:Gd sample. F11 F11_grey: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in water. F11_red: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in MES medium. F11_blue: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in PBS medium. F11_green: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in saline medium. F12 F12_Histogram_1 day: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during one day. F12_Histogram_21 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 21 days. F12_Histogram_35 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 35 days. F13 F13d_Analysis of the total number of cells per well exposed to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13e_Dead cell percentage to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13f_Mitochondrial activity of the cells to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. FS1 FS1a_Size distribution histogram of the single-phase nanoparticles containing Gd and Dy as a solid solution. FS1b_Size distribution histogram of the DyVO4 nanoparticles coated with a GdVO4 shell. FS1c_Size distribution histogram of the DyVO4 nanoparticles coated with a first YVO4 shell and with a second shell consisting of GdVO4 doped with Nd3+. FS2 FS2b_Size distribution histogram for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2c_ DLS curve in water suspension for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_XRD pattern for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_DyVO4_PDF FS2e_FTIR spectrum for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2f_TGA curve for the DyVO4 nanoparticles functionalized with PAA used as cores., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., Elisabet Gómez-González, Carlos Caro, Nuria O. Núñez, Daniel González-Mancebo, Jesús D. Urbano-Gámez, María L. García-Martín and Manuel Ocaña. Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging. Journal of Materials Chemistry B [In press], Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based nanoparticles as multimodal T1 -T2 MRI contrast agent and NIR luminescent imaging probe

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your Future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset -Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Files List: Figure 1 F1b_Particle size histogram (b) of the synthesized nanoparticles Figure 2 F2a_blue XRD pattern of the synthesized nanoparticles F2a_red ticks corresponding to the tetragonal NaDy(WO4)2 (25-829 PDF file). F2b_FTIR spectrum of the tetragonal NaDy(WO4)2 nanoparticles F2c_TGA curve of the tetragonal NaDy(WO4)2 nanoparticles. Figure 3 F3_MES_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 0 h. F3_MES_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 24 h. F3_MES_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 48 h. F3_MES_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 72 h. F3_Saline_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 0 h. F3_Saline_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 24 h. F3_Saline_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 48 h. F3_Saline_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 72 h. F3_Water_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 0 h. F3_Water_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 24 h. F3_Water_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 48 h. F3_Water_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 72 h. Figure 5 F5c_Percentage of dead cells obtained from live-dead analysis F5d_black_Negative and positive control for live-dead analysis F5d_cyan_total number of cells per well obtained from live-dead analysis Figure 6 F6_black_negative and positive control for MTT assay F6_cyan_Mitochondrial activity of cells exposed to increasing concentration of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles evaluated by MTT assay Figure 7 F7c_EDX spectrum taken from the region marked with a white square in Figure 7 (a). Figure 8 F8_left_Viability of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h F8_right_Brood size (right) of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h Figure 9 F9a_blue_Relaxation rates 1/T1 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9a_red_Relaxation rates 1/T1 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_blue_Relaxation rates 1/T2 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_red__Relaxation rates 1/T2 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles Figure 11 F11_green_X-ray attenuation values (in Hounsfield units, HU) of NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water F11_ red_X-ray attenuation values (in Hounsfield units, HU) of iohexol dispersed in water, Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020-118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Open Access Article. Published on 10 October 2025. Downloaded on 10/10/2025 10:25:41 AM. This article is licensed under a which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed